Dexamethasone for cancer-related dyspnoea - Authors' reply.

Saved in:
Bibliographic Details
Title: Dexamethasone for cancer-related dyspnoea - Authors' reply.
Authors: Hui D; Department of General Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Palliative Care, Rehabilitation, and Integrative Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: dhui@mdanderson.org., Hanneman SK; Cizik School of Nursing at UTHealth, The University of Texas Health Science Center at Houston, Houston, TX, USA., Mahler DA; Geisel School of Medicine at Dartmouth, Hanover, NH, USA; Respiratory Services, Valley Regional Hospital, Claremont, NH, USA., Bruera E; Department of Palliative Care, Rehabilitation, and Integrative Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Source: The Lancet. Oncology [Lancet Oncol] 2022 Dec; Vol. 23 (12), pp. e526.
Publication Type: Letter; Comment
Journal Info: Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1474-5488
DOI:10.1016/S1470-2045(22)00699-4